Skip to main navigation Skip to search Skip to main content

Correction to: Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro (Medical Oncology, (2022), 39, 7, (88), 10.1007/s12032-022-01671-6)

  • Xiaoyu Yang
  • , Yan Wang
  • , Heshu Sulaiman Rahman
  • , Talar A.M. Mohammad
  • , Stanislav Evgenievich Korsakov
  • , Lakshmi Thangavelu
  • , Ali Adili
  • , Rozita Tamjidi Far
  • , Hossein Saeedi
  • , Ramin Aslaminabad
  • , Saeed Tarzi
  • , Morteza Akbari
  • Zhengzhou University
  • University of Sulaimani
  • Hawler Medical University
  • Sechenov First Moscow State Medical University
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • Tabriz University of Medical Sciences
  • Moffitt Cancer Center

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained a mistake. The corrected details are given below. (a) The following co-authors name has been included in the author group mistakenly: Amin Daei Sorkhabi, Aila Sarkesh. However, these author names are removed from the author group. (b) The spell error in the co-author names “Talar Ahmad Merza Mohammad, Rozita Tamjidifar” should be corrected as “Talar AM Mohammad, Rozita Tamjidi Far”.(c) The second affiliation of co-author “Ali Adili” must be "Senior Adult Oncology Department, Moffitt Cancer Center, University of South Florida, Florida, USA".

Original languageEnglish
Article number138
JournalMedical Oncology
Volume39
Issue number9
DOIs
StatePublished - Sep 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro (Medical Oncology, (2022), 39, 7, (88), 10.1007/s12032-022-01671-6)'. Together they form a unique fingerprint.

Cite this